Netideas

Tuberous Sclerosis Alliance Inc, based in Philadelphia, PA, is a non-profit organization dedicated to raising awareness and supporting individuals affected by tuberous sclerosis complex (TSC). Through advocacy efforts and community outreach, the organization strives to improve the quality of life for those living with TSC. With a focus on education and research, Tuberous Sclerosis Alliance Inc works to advance understanding of TSC and promote access to resources for patients and their families. By fostering collaboration among healthcare professionals and individuals impacted by TSC, the organization aims to enhance treatment options and provide a supportive network for those navigating this complex condition. Generated from their business information

Strategic Management Services is a leading healthcare compliance consulting firm based in Philadelphia, PA, offering specialized services developed by industry experts to help healthcare organizations meet regulatory requirements. With a focus on compliance program design, implementation, and effectiveness evaluation, the firm works with a diverse range of healthcare entities to manage and improve their compliance operations. Empowering clients to navigate the complex regulatory landscape, Strategic Management Services provides expert insights and tools for assessing and managing the impact of evolving government compliance and enforcement initiatives. From privacy and security program design to revenue integrity consulting, the firm's comprehensive services aim to support healthcare organizations in achieving and maintaining regulatory compliance.Generated from the website

ConquerAb Inc, based in Philadelphia, PA, specializes in innovative rapid diagnostics for detecting antibody responses against biotherapeutic protein drugs. Their proprietary disposable devices enable point-of-care and at-home testing, providing results in under 15 minutes with just a drop of blood. The company addresses the unmet need for reliable immunogenicity monitoring, facilitating risk assessment and precision medicine for patients undergoing treatment for various diseases. With a focus on standardizing antibody detection, ConquerAb Inc aims to enhance the efficacy and safety of biotherapeutics in a growing multibillion-dollar market. Generated from the website